CSS LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

CSS LLC’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24,702	Closed	-$255K	–	834
2020 Q2	$255K	Buy	+24,702	New	+$253K	0.01%	461

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CSS LLC's IRWD Position: Q3 2020 in Review

CSS LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 24,702 shares — an estimated $255K sold.

CSS LLC first reported a position in IRWD in Q2 2020 and held it in 1 quarter. The position peaked at $255K in Q2 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

CSS LLC reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
CSS LLC sold 24,702 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $255K.
CSS LLC first reported a position in Ironwood Pharmaceuticals in Q2 2020 and held it in 1 quarter.
CSS LLC's Ironwood Pharmaceuticals position peaked at $255K in Q2 2020.
190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on CSS LLC's 13F filing for Q3 2020, filed 16 Nov 2020.